Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119255) titled 'Clinical study on the efficacy of Telitacicept in IgA nephropathy' on Feb. 25.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: The First Affiliated Hospital of Wenzhou Medical University
Condition:
Proteinuria
Intervention:
Tasimacicib group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-25
Target Sample Size: Tasimacicib group:150;Control group:1850;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=310063
Published by HT Digital Content Services with permission from Health Da...